| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/25/2006 | US7034153 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/25/2006 | US7034131 Antibody therapy; immobilization |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034049 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034031 Modulators of TNF-α signaling |
| 04/25/2006 | US7034028 Treatment of inflammatory disorders |
| 04/25/2006 | US7034027 Method of treating a male or female animal in the treatment of a condition where inhibition of a cGMP-specific PDE is of a therapeutic benefit comprising treating said animal with an effective amount of a pharmaceutical composition with carriers |
| 04/25/2006 | US7034022 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections |
| 04/25/2006 | US7034017 Substituted oxazolidinones and their use in the field of blood coagulation |
| 04/25/2006 | US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors |
| 04/25/2006 | US7034014 Phosphonate compounds |
| 04/25/2006 | US7033807 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 04/25/2006 | US7033794 Basolateral sorting signal and inhibitors thereof |
| 04/25/2006 | US7033615 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues |
| 04/25/2006 | CA2522899C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2521956C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1-h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 04/25/2006 | CA2521908C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2521891C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2521887C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2521833C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 04/25/2006 | CA2521828C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 04/25/2006 | CA2521792C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2521776C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 04/25/2006 | CA2438097C Cannabinoids pharmaceutical formulations |
| 04/25/2006 | CA2296374C Semi-interpenetrating polymer networks |
| 04/20/2006 | WO2006042104A2 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 04/20/2006 | WO2006041019A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same |
| 04/20/2006 | WO2006041015A1 Amino alcohol derivative, addition salt thereof and immunosuppressive agent |
| 04/20/2006 | WO2006040666A1 Substituted n-alkylpyrimidinones |
| 04/20/2006 | WO2006039763A1 Vitamin d3 analogues for the prevention and treatment of bone disorders |
| 04/20/2006 | WO2006021803A3 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
| 04/20/2006 | WO2006018609A3 Anti-inflammatory agents |
| 04/20/2006 | WO2006000577A9 Lxr agonists to promote bone homeostasis |
| 04/20/2006 | WO2005063218A3 Pharmaceutical formulations of bisphosphonates |
| 04/20/2006 | US20060084809 Compounds as PDE IV and TNF-inhibitors |
| 04/20/2006 | US20060084803 Bicyclic pyridine and pyrimidine P38 kinase inhibitors |
| 04/20/2006 | US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 04/20/2006 | US20060084685 Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 04/20/2006 | US20060084684 Topically applicable pharmaceutical preparation |
| 04/20/2006 | US20060084677 2-sulfo, sulfanyl, sulfinyl, sulfonyl, or sulfamyl-5-substituted-6-sulfonyl quinolines; sulfiding, oxidation, dehalogenation or aralkylation of the 6-sulfonylquinoline; selective cyclooxygenase-2 inhibitors, analgesics; side effect reduction |
| 04/20/2006 | US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/20/2006 | US20060084661 IL-8 receptor antagonists |
| 04/20/2006 | US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 04/20/2006 | US20060084641 IL-8 receptor antagonists |
| 04/20/2006 | US20060084613 Dipeptide enzyme inhibitor; antiinflammatory agents; autoimmune disease; wound healing agents |
| 04/20/2006 | US20060084595 Complex comprising OCIF and polysaccharide |
| 04/20/2006 | US20060084135 Compositions for manipulating the lifespan and stress response of cells and organisms |
| 04/20/2006 | US20060084121 OX2 receptor homologs |
| 04/20/2006 | US20060083792 Utilizing nanocrystalline silver metal, alloy or compound for localized tissue infections; reducing side effects; limiting overuse of antibiotics |
| 04/20/2006 | US20060083787 Intraarticularly injecting a fluid in the joint space of an animal; the replacement fluid is synovial fluid that has been harvested from other animals and processed to remove impurities, cellular and pathogenic components, then lyophilized, packaged and reconstituted |
| 04/20/2006 | US20060083784 Amorphous pharmaceutical compositions |
| 04/20/2006 | US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies |
| 04/20/2006 | US20060083711 Methods and products related to the intracellular delivery of polysaccharides |
| 04/20/2006 | DE102004050196A1 Substituierte 2-Pyridon-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted 2-pyridone derivatives, processes for their preparation and their use as a medicament |
| 04/20/2006 | DE10127897B4 Manteltablette mit Pflanzentrockenextrakten Coated tablet with dry plant extracts |
| 04/20/2006 | CA2584293A1 Crig polypeptide for prevention and treatment of complement-associated disorders |
| 04/20/2006 | CA2583846A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrates thereof, and intermediates in the production thereof |
| 04/20/2006 | CA2583092A1 Antiangiogenic calixarene-based peptide mimetics |
| 04/20/2006 | CA2580497A1 Substituted n-alkylpyrimidinones |
| 04/19/2006 | EP1646656A2 Human antibody molecules for il-13 |
| 04/19/2006 | EP1646634A1 Use of rapamycin and rapamycin derivatives for the treatment of bone loss |
| 04/19/2006 | EP1646392A2 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 04/19/2006 | EP1646376A1 Use of cis-9, trans-11 isomer of conjugated linoleic acid (cla) for treating inflammatory diseases |
| 04/19/2006 | EP1556140A4 Novel compounds |
| 04/19/2006 | EP1537112B1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 04/19/2006 | EP1474122A4 Compounds for blocking androgen receptors |
| 04/19/2006 | EP1448564B1 Substituted indolizine-like compounds and methods of use |
| 04/19/2006 | EP1387838B1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 04/19/2006 | EP1370559B1 Triazolopyridines as anti-inflammatory agents |
| 04/19/2006 | EP1365777B1 Compositions comprising proteoglycan and their use for the treatment of inflammatory conditions |
| 04/19/2006 | EP1296959B1 Methods and compositions utilizing quinazolinones |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/19/2006 | EP1259125B1 Inulin products with improved nutritional properties |
| 04/19/2006 | EP1216067B1 Polyhydroxyalkanoate compositions for soft tissue repair, augmentation, and viscosupplementation |
| 04/19/2006 | EP1212330B1 Androgen receptor modulator compounds and methods |
| 04/19/2006 | EP1143806B1 Method for increasing pet activity |
| 04/19/2006 | CN1761686A Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 04/19/2006 | CN1761664A Immunomodulating heterocyclic compounds |
| 04/19/2006 | CN1761481A Osteogenic composition |
| 04/19/2006 | CN1760200A Preparing model compound of lipoxygenase and application |
| 04/19/2006 | CN1759868A Plaster for treating fracture and hyperosteogeny |
| 04/19/2006 | CN1759864A Medicine wine for activating the channels |
| 04/19/2006 | CN1759858A Prescription of compound unique oil drop pills and preparation method |
| 04/19/2006 | CN1759853A medication for treating bone injuries |
| 04/19/2006 | CN1252069C 2-aryl-naphthyridin-4-ones as antitumor agent |
| 04/19/2006 | CN1252067C Benzazole derivatives and their use as JNK modulators |
| 04/19/2006 | CN1252065C Cinnoline compounds |
| 04/19/2006 | CN1252040C Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives |
| 04/19/2006 | CN1251747C Medicine for treating burns, scalds, other multiple skin disease and traumatic injury |
| 04/19/2006 | CN1251735C Chinese patent medicine for treating thigh-bong necrosis |
| 04/19/2006 | CN1251726C Ointment for treating osteoarticular tuberculosis, osteomyelitis and sterile thigh-bong necrosis |
| 04/19/2006 | CN1251710C Quick-effective externally used medicine for treating traumatic injury and its preparing method |
| 04/19/2006 | CN1251708C Traditional Chinese herb medicine plaster for treating bone injury, and its prepn. method |
| 04/19/2006 | CN1251707C Application of Engally nut oil in the preparation of medicine for treating arthritis |
| 04/18/2006 | US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment |
| 04/18/2006 | US7030218 Extending ligation technique to peptides, polypeptides, other polymers and other molecules via an amide bond; used in the synthesis of optionally polymer-modified, synthetic bioactive proteins, and of pharmaceutical compositions |
| 04/18/2006 | US7030157 Hormone replacment therapy; anticancer agent; sexual disorders |
| 04/18/2006 | US7030135 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia |
| 04/18/2006 | US7030133 Inhibitors of formation of advanced glycation endproducts (AGEs) |